Search results
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoXenon Pharmaceuticals Inc. (NASDAQ:XENE) Q4 2023 Earnings Call Transcript February 29, 2024 Xenon...
Real estate: Industrial warehouse sells for $2.6 million in Jackson Township
The Repository via Yahoo Finance· 2 months agoAn industrial building on Freedom Avenue NW in Jackson Township sold for $2.6 million, according to...
Satsuma Pharma Shares Nosedives After Disappointing Data From Migraine Study
Benzinga via Yahoo Finance· 1 year agoSatsuma Pharmaceuticals Inc (NASDAQ: STSA) shares are falling after the company reported topline...
Q3 2023 Ionis Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 months agoParticipants Brett P. Monia; Founder, CEO & Director; Ionis Pharmaceuticals, Inc. D. Wade Walke; SVP of IR; Ionis Pharmaceuticals, Inc. Elizabeth L. Hougen; Executive VP of Finance & CFO; Ionis ...
Satsuma Pharma Shares Are Gaining After Encouraging Update From Migraine Candidate
Benzinga via Yahoo Finance· 2 years agoSatsuma Pharmaceuticals Inc (NASDAQ: STSA) announced favorable safety, tolerability, and efficacy...
This Stock Earns Price Bump, Bullish Pitch On Recent Positive Migraine Drug Data
Benzinga via Yahoo Finance· 2 years agoSatsuma Pharmaceuticals Inc (NASDAQ: STSA) announced positive results from the ASCEND open-label,...
KORU Medical (KRMD) Forms New Deal on Subcutaneous Infusion
Zacks via Yahoo Finance· 1 month agoKORU Medical Systems, Inc. KRMD has made a strategic move in its pursuit of expanding its footprint...
Xenon's Epilepsy Candidate Rapidly Reduces Focal Onset Seizure Frequency
Benzinga via Yahoo Finance· 2 years agoXenon Pharmaceuticals Inc (NASDAQ: XENE) announced new efficacy data supporting the Phase 3...
Court Favors Vanda In Case Against FDA Over Detail Disclosure Of Rejection Of Sleep Disorder Drug
Benzinga via Yahoo Finance· 1 year agoA federal court granted final judgment in favor of Vanda Pharmaceuticals Inc's (NASDAQ: VNDA)...
Talaris (TALS) Down on Patient Death From Renal Transplant Study
Zacks via Yahoo Finance· 2 years agoTalaris Therapeutics (TALS) reports a patient death from its late-stage study evaluating its...
